Archive for Akavar 20/50
You are browsing the archives of Akavar 20/50.
You are browsing the archives of Akavar 20/50.
A suit seeking class action status was filed against Basic Research, Dynakor Pharmacal, Western Holdings and Dennis Gay, Daniel B. Mowrey, Ph.D.; and Mitchell Friedlander. The filed complaint claims that the defendants ‘engaged in a deliberate campaign of widespread fraud and deception’ by marketing Akavar 20/50 with false claims that taking it could result in [...]